Stay updated with breaking news from Lexaria Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lexaria Bioscience Corp. (NASDAQ:LEXX – Get Free Report) was the target of a large increase in short interest during the month of September. As of September 30th, there was short interest totalling 422,900 shares, an increase of 14.5% from the September 15th total of 369,200 shares. Approximately 5.8% of the shares of the company are […]
Shares of Lexaria Bioscience Corp. (OTCMKTS:LXRP – Get Free Report) crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.22 and traded as high as $0.25. Lexaria Bioscience shares last traded at $0.22, with a volume of 2,151,500 shares. Lexaria Bioscience Stock Performance The firm […]
Drug Delivery Platform Innovator With Multiple Mainstream Applications Investor Presentation Q3 2023 ...
LEXARIA BIOSCIENCE CORP. NASDAQ: LEXX INVESTOR CONTACT Phone: 250-765-6424 ext. 202...
Lexaria Provides Update on Investigational New Drug Application Progress ...